Consolidated Balance Sheet

Oncolys BioPharma Inc. - Filing #7712397

Concept As at
2019-03-31
As at
2018-12-31
Consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
2,331,795,000 JPY
2,463,138,000 JPY
Accounts receivable - other
33,338,000 JPY
27,843,000 JPY
Accounts receivable - trade
48,383,000 JPY
50,063,000 JPY
Prepaid expenses
26,652,000 JPY
29,438,000 JPY
Supplies
1,831,000 JPY
1,941,000 JPY
Other
766,000 JPY
726,000 JPY
Current assets
2,496,940,000 JPY
2,618,115,000 JPY
Non-current assets
813,560,000 JPY
811,997,000 JPY
Investments and other assets
809,916,000 JPY
809,740,000 JPY
Investment securities
668,617,000 JPY
668,201,000 JPY
Investments in capital
100,000 JPY
100,000 JPY
Long-term prepaid expenses
776,000 JPY
865,000 JPY
Other
19,000 JPY
19,000 JPY
Non-current assets
Property, plant and equipment
Buildings, net
JPY
JPY
Property, plant and equipment
3,643,000 JPY
2,256,000 JPY
Investments and other assets
Assets
3,310,500,000 JPY
3,430,112,000 JPY
Liabilities
Current liabilities
Short-term borrowings
150,008,000 JPY
83,336,000 JPY
Deposits received
6,612,000 JPY
4,402,000 JPY
Accounts payable - other
67,539,000 JPY
71,012,000 JPY
Income taxes payable
16,016,000 JPY
35,933,000 JPY
Lease liabilities
4,327,000 JPY
5,795,000 JPY
Accrued expenses
11,690,000 JPY
11,845,000 JPY
Current liabilities
256,193,000 JPY
212,324,000 JPY
Non-current liabilities
Long-term borrowings
436,098,000 JPY
311,104,000 JPY
Lease liabilities
870,000 JPY
1,345,000 JPY
Non-current liabilities
441,334,000 JPY
316,634,000 JPY
Liabilities
697,528,000 JPY
528,959,000 JPY
Liabilities and net assets
Shareholders' equity
2,616,294,000 JPY
2,903,953,000 JPY
Share capital
6,437,421,000 JPY
6,402,658,000 JPY
Deposits for subscriptions of shares
3,000,000 JPY
JPY
Capital surplus
6,429,921,000 JPY
6,395,158,000 JPY
Retained earnings
-10,254,048,000 JPY
-9,893,863,000 JPY
Valuation and translation adjustments
-12,693,000 JPY
-13,108,000 JPY
Valuation difference on available-for-sale securities
-12,693,000 JPY
-13,108,000 JPY
Share acquisition rights
9,371,000 JPY
10,309,000 JPY
Net assets
2,612,972,000 JPY
2,901,153,000 JPY
Liabilities and net assets
3,310,500,000 JPY
3,430,112,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments

Talk to a Data Expert

Have a question? We'll get back to you promptly.